AZGP1 and neoplasm: Invasive and migratory assays, along with assessments of epithelial–mesenchymal transition (EMT)-related proteins in the representative PC3 and 22RV1 cell lines, confirmed our hypothesis: low AZGP1 expression enhances cell invasion and migration, promoting tumor cell metastasis.